Display options
Cite
Anfuso B, Tiribelli C, Sukowati CH. Recent insights into hepatic cancer stem cells. Hepatol Int. 2013;8:458-63doi: 10.1007/s12072-013-9498-0.
Anfuso, B., Tiribelli, C., & Sukowati, C. H. (2014). Recent insights into hepatic cancer stem cells. Hepatology international, 8458-63. https://doi.org/10.1007/s12072-013-9498-0
Anfuso, Beatrice, et al. "Recent insights into hepatic cancer stem cells." Hepatology international vol. 8 (2014): 458-63. doi: https://doi.org/10.1007/s12072-013-9498-0
Anfuso B, Tiribelli C, Sukowati CH. Recent insights into hepatic cancer stem cells. Hepatol Int. 2014 Sep;8:458-63. doi: 10.1007/s12072-013-9498-0. Epub 2013 Dec 20. PMID: 26201324.
Copy Download .nbib Format: NLM
Share it on

Hepatol Int. 2014 Sep;8:458-63. doi: 10.1007/s12072-013-9498-0. Epub 2013 Dec 20.

Recent insights into hepatic cancer stem cells.

Hepatology international

Beatrice Anfuso, Claudio Tiribelli, Caecilia H C Sukowati

Affiliations

  1. Fondazione Italiana Fegato, AREA Science Park Basovizza, 34149, Trieste, Italy.
  2. Department of Medical Sciences, University of Trieste, 34100, Trieste, Italy.
  3. Fondazione Italiana Fegato, AREA Science Park Basovizza, 34149, Trieste, Italy. [email protected].
  4. Department of Medical Sciences, University of Trieste, 34100, Trieste, Italy. [email protected].

PMID: 26201324 DOI: 10.1007/s12072-013-9498-0

Abstract

It has been suggested that the development of hepatocellular carcinoma (HCC) is related to the existence of cancer stem cells (CSCs) or tumor-initiating cells. Although CSCs populations may be recognized by use of stem cell markers and/or their functional capacities, their profiles might be diverse, because of the heterogeneity of HCC among individuals. Recent studies indicate that activation of CSCs is related to dysregulation of crucial molecular signaling pathways able to alter the intrinsic properties of normal stem cells. This short review describes the latest evidence of the presence of CSCs, alteration of several developmental and oncogenic pathways, CSC-related microRNAs, and drug resistance in HCC. This information may aid the development of potential novel therapy targeting CSCs in HCC.

Keywords: Cancer stem cells; Drug resistance; Hepatocellular carcinoma; Signaling pathways

References

  1. Hepatogastroenterology. 2012 Oct;59(119):2238-42 - PubMed
  2. J Clin Invest. 2010 Sep;120(9):3326-39 - PubMed
  3. PLoS One. 2011;6(6):e21369 - PubMed
  4. Mol Cancer Res. 2008 Jul;6(7):1146-53 - PubMed
  5. Hum Cell. 2006 Feb;19(1):24-9 - PubMed
  6. Gastroenterology. 2007 Jun;132(7):2542-56 - PubMed
  7. Hepatology. 2013 Feb;57(2):840-7 - PubMed
  8. Tumori. 2010 Jan-Feb;96(1):90-6 - PubMed
  9. Chin J Cancer. 2012 May;31(5):223-32 - PubMed
  10. Cancer Res. 2007 Nov 15;67(22):10831-9 - PubMed
  11. J Cell Physiol. 2011 May;226(5):1214-23 - PubMed
  12. Oncogene. 2003 Oct 20;22(47):7340-58 - PubMed
  13. Int J Cancer. 2010 May 1;126(9):2067-78 - PubMed
  14. Anticancer Res. 2011 Aug;31(8):2603-8 - PubMed
  15. Cancer Res. 2010 Jun 1;70(11):4687-97 - PubMed
  16. Genome Res. 2013 Sep;23 (9):1422-33 - PubMed
  17. Int J Cancer. 2012 Jun 1;130(11):2557-67 - PubMed
  18. Dig Liver Dis. 2010 Jul;42 Suppl 3:S206-14 - PubMed
  19. Cell Biosci. 2011 Jan 18;1(1):4 - PubMed
  20. Mol Cancer Ther. 2002 Apr;1(6):417-25 - PubMed
  21. Chin J Cancer. 2013 Aug;32(8):419-26 - PubMed
  22. BMC Gastroenterol. 2011 Jun 14;11:71 - PubMed
  23. Hepatology. 2006 Jul;44(1):240-51 - PubMed
  24. J Cancer Res Clin Oncol. 2008 Nov;134(11):1155-63 - PubMed
  25. Int J Biol Sci. 2012;8(7):992-1004 - PubMed
  26. Oncol Rep. 2012 Jun;27(6):1865-72 - PubMed
  27. Hepatology. 2013 Apr;57(4):1484-97 - PubMed
  28. Biochem Biophys Res Commun. 2006 Dec 29;351(4):820-4 - PubMed
  29. BMC Gastroenterol. 2012 Nov 15;12 :160 - PubMed
  30. J Huazhong Univ Sci Technolog Med Sci. 2007 Apr;27(2):173-5 - PubMed
  31. PLoS One. 2012;7(9):e44206 - PubMed
  32. PLoS One. 2013 May 21;8(5):e63436 - PubMed
  33. Hepatology. 2012 Dec;56(6):2255-67 - PubMed
  34. Cancer Cell. 2013 Apr 15;23(4):541-56 - PubMed
  35. Gastroenterology. 2009 Mar;136(3):1012-24 - PubMed
  36. Carcinogenesis. 2008 Dec;29(12 ):2289-97 - PubMed
  37. J Hepatol. 2010 Feb;52(2):280-1 - PubMed
  38. Cancer Lett. 2013 Jul 28;335(2):455-62 - PubMed
  39. Cell Stem Cell. 2010 Dec 3;7(6):694-707 - PubMed
  40. J Hepatol. 2012 Jun;56(6):1371-83 - PubMed
  41. Hepatology. 2010 Aug;52(2):528-39 - PubMed
  42. Mol Cancer Ther. 2013 Aug;12 (8):1651-64 - PubMed
  43. Gastrointest Cancer Res. 2008 Jul;2(4 Suppl):S27-30 - PubMed
  44. Int J Oncol. 2012 Mar;40(3):747-56 - PubMed
  45. J Int Med Res. 2011;39(6):2323-9 - PubMed
  46. Cancer Res. 2008 Oct 1;68(19):7742-9 - PubMed
  47. Nature. 2001 Nov 1;414(6859):105-11 - PubMed
  48. Int J Cancer. 2007 Apr 1;120(7):1444-50 - PubMed
  49. Int J Cancer. 2010 Dec 15;127(12):2893-917 - PubMed
  50. Carcinogenesis. 2010 Sep;31(9):1516-22 - PubMed
  51. Ann Oncol. 2012 Sep;23 (9):2306-13 - PubMed
  52. Hepatology. 2008 Mar;47(3):919-28 - PubMed
  53. Cancer Cell. 2008 Feb;13(2):153-66 - PubMed
  54. Hepatology. 2013 Apr;57(4):1469-83 - PubMed
  55. Cell Stem Cell. 2011 Jul 8;9(1):50-63 - PubMed
  56. J Biol Chem. 2011 Sep 2;286(35):30706-13 - PubMed
  57. Oncologist. 2010;15 Suppl 4:5-13 - PubMed
  58. Biochem Biophys Res Commun. 2006 May 5;343 (2):571-7 - PubMed
  59. Cell. 2009 May 15;137(4):647-58 - PubMed
  60. Cell Reprogram. 2013 Apr;15(2):143-50 - PubMed
  61. N Engl J Med. 2013 Jun 13;368(24):2266-76 - PubMed
  62. Hepatology. 2013 Jul;58(1):205-17 - PubMed
  63. J Cell Biochem. 2007 Sep 1;102(1):75-81 - PubMed
  64. BMC Cancer. 2010 Jul 06;10:354 - PubMed
  65. Cancer Res. 2008 Jun 1;68(11):4287-95 - PubMed

Publication Types